dc.contributorTornero Molina, J., Departamento de Medicina, Universidad de Alcal�, Hosp. Gen. Univ. de Guadalajara, Guadalajara, Mexico, Servicio de Reumatolog�a, Hosp. Gen. Univ. de Guadalajara, Donantes de Sangre, s/n, 19002 Guadalajara, Mexico
dc.creatorTornero Molina, J.
dc.date.accessioned2015-09-15T17:41:27Z
dc.date.accessioned2022-11-02T15:07:48Z
dc.date.available2015-09-15T17:41:27Z
dc.date.available2022-11-02T15:07:48Z
dc.date.created2015-09-15T17:41:27Z
dc.date.issued2003
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-0038657778&partnerID=40&md5=22a2f8ed76c9a46d2383508585463975
dc.identifierhttp://hdl.handle.net/20.500.12104/40619
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5009549
dc.description.abstractThe use of nonsteroidal antiinflammatory drugs (NSAID) combined with oral anticoagulants (OA) has the risk of interactions that could increase the risk of bleeding complications. A review of the mechanisms and clinical significance of these adverse interactions between NSAIDs, including the new COX-2 specific inhibitors (COXIB), and OA, is discussed.
dc.relationScopus
dc.relationSeminarios de la Fundacion Espanola de Reumatologia
dc.relation4
dc.relation2
dc.relation62
dc.relation65
dc.titleDiclofenac is the NSAID that an anticoagulated patient should take [El AINE que debe tomar el paciente anticoagulado es el diclofenaco]
dc.typeReview


Este ítem pertenece a la siguiente institución